R Squared’s Cardiff Oncology CRDF Stock Holding History
Bought
Maintained
Sold
Other funds holding CRDF
LCM
P
R Squared's CRDF Position: Q2 2026 in Review
R Squared increased its Cardiff Oncology (CRDF) stake by 87% in Q2 2026, buying an estimated $16.2K and bringing the position to 22,018 shares worth $28.6K. The position accounts for 0.02% of the portfolio, ranked #474.
R Squared first reported a position in CRDF in Q4 2024 and has held it in 4 quarters since. The position peaked at $35.7K in Q4 2025. 105 funds tracked by Wall St. Rank hold CRDF as of Q2 2026.
- R Squared held 22,018 shares of Cardiff Oncology worth $28.6K as of Q2 2026.
- R Squared bought 10,216 Cardiff Oncology shares in Q2 2026, an estimated $16.2K.
- Cardiff Oncology made up 0.02% of R Squared's portfolio in Q2 2026, its #474 holding.
- R Squared first reported a position in Cardiff Oncology in Q4 2024 and has held it in 4 quarters since.
- R Squared's Cardiff Oncology position peaked at $35.7K in Q4 2025.
- 105 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2026.
Based on R Squared's 13F filing for Q2 2026, filed 5 Aug 2026.